Based on evidence, synbiotics may confer their hypotriglyceridemic effects through impeding triglyceride absorption from the gut, via stimulating GLP-1 levels (75), stimulating the secretion of FIAF, by which inhibiting endothelial LPL, which may lead to decreased release of triglycerides from circulating chylomicrons and very-low-density lipoprotein (VLDL) (76), and lowering TG levels through reducing hepatic de novo lipogenesis, induced by carbohydrate-responsive element-binding protein (ChREBP) and sterol regulatory element-binding protein (SREBP) (76)
ALCAR also helps transport toxic compounds out of the mitochondria, supporting overall cellular health and energy metabolism
The Ozempic lawsuit names Novo Nordisk, the manufacturers of Ozempic, as well as Eli Lilly, the manufacturers of Trulicity, as the responsible entities
While Cocova-L is generally well tolerated, some patients may experience